Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 10889 - 10896 of 12011 results
Health Canada Releases New Guidelines for Civil Penalties System
September 23, 2013| Blog| Viewpoint
OCR Delays Required Changes to Notices of Privacy Practices for Laboratories
September 20, 2013| Blog| Viewpoint
OCR Clarifies Scope of HIPAA Prescription Refill Reminder Exception
September 20, 2013| Blog| Viewpoint
It’s Time to Register for the 2015 Diversity Immigrant Visa Lottery!
September 20, 2013| Blog| Viewpoint
California's Low Carbon Fuel Standard Upheld after Initial Defeat in Federal Court
September 19, 2013| Blog| Viewpoint
Interagency Initiative Targets Consumer Fraud in the ACA Exchange Marketplace
September 19, 2013| Blog| Viewpoint
Product Liability Lawyers at the Drawing Board: Risk Assessment Begins at the Beginning
September 19, 2013| Blog| Viewpoint
FTC Seeks Public Comment on Proposed kidSAFE COPPA Safe Harbor Program
September 18, 2013| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|